Lytic infection by herpesviruses induces cell cycle arrest at the G1/S transition. This appears to 21 be a function of multiple herpesvirus proteins but only a minority of herpesvirus proteins have 22 been examined for cell cycle effects. To gain a more comprehensive understanding of the viral 23 proteins that contribute to G1/S arrest, we screened a library of over 200 proteins from herpes 24 simplex virus type 1, human cytomegalovirus and Epstein-Barr virus (EBV) for effects on the 25 G1/S interface, using HeLa Fucci cells in which G1/S can be detected colorimetrically. Proteins 26 from each virus were identified that induce accumulation of G1/S cells, predominantly tegument, 27 early and capsid proteins. The identification of several capsid proteins in this screen suggests 28 that incoming viral capsids may function to modulate cellular processes. The cell cycle effects of 29 selected EBV proteins were further verified and examined for effects on p53 and p21 as 30 regulators of the G1/S transition. Two EBV replication proteins (BORF2 and BMRF1) were 31 found to induce p53 but not p21, while a previously uncharacterized tegument protein (BGLF2) 32 was found to induce p21 protein levels in a p53-independent manner. Proteomic analyses of 33 BGLF2-interacting proteins identified interactions with NEK9 kinase and GEM interacting 34 protein (GMIP). Silencing of either NEK9 or GMIP induced p21 without affecting p53 and 35 abrogated the ability of BGLF2 to further induce p21. Collectively, these results suggest 36 multiple viral proteins contribute to G1/S arrest, including BGLF2, which induces p21 levels 37 likely by interfering with the functions of NEK9 and GMIP. Most people are infected with multiple herpesviruses, whose proteins alter the infected cells in 41 several ways. During lytic infection, the viral proteins block cell proliferation just before the 42 cellular DNA replicates. We used a novel screening method to identify proteins from three 43 different herpesviruses that contribute to this block. Several of the proteins we identified had 44 previously unknown functions or were structural components of the virion. Subsets of these 45
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Immunofluorescence microscopy. Cells seeded at 50% confluency on coverslips in 6-welland geminin (mAG-hGem) were excited using a 488 nm laser and fluorescent signals were 168 collected at 585 nm (585/42 nm BP, FL2) and 530nm (530/30 nm BP, FL1), respectively. FLAG 169 expression was detected using a 661/16 nm BP filter cube (FL4). Samples were initially sorted 170 on the expression of the FLAG epitope, then Cdt1 (G1), geminin (S/G2/M), or both (G1/S) were 171 gated as described in Sakue-Sawano et al (26) in FLAG-positive and FLAG-negative 172 populations. The data were analyzed using FloJo software (Tree Star). Research). The primers used to measure p21 and GAPDH transcripts were previously reported 222 (34). Data were analyzed using the ΔΔCt method, with transcript levels being normalized to 223 GAPDH. p21 transcript levels determined after transfection with pMZS3F-BGLF2 were 224 expressed as fold change over those determined after transfection with the pMZS3F empty 225 vector. When etoposide treatment was used, it was added into the media at a concentration of 5 226 mM for 24 hours. (Swiss-Prot accession number P02769). Search parameters were set to allow for two missed 243 cleavage sites, variable modification by methionine oxidation, and one fixed modification by 244 cysteine carbamidomethylation. A 10 ppm filter was used for peptide identification. The search 245 results were uploaded to Prohits (36) and compared using at least 99% TPP probability. 246
247
Silencing experiment. Cells were seeded into 6 cm tissue culture dishes at 50% confluency and 248 immediately transfected with 100 pmol of siRNA against NEK9 or GMIP or AllStars negative 249 control siRNA (Qiagen) using Lipofectamine 2000. Forty-eight hours later, cells were subjected 250 to a second round of siRNA treatment. Twenty-four hours after this, cells were either harvested 251 directly, or transfected with pMZS3F or pMZS3F-BGLF2 using Lipofectamine 2000, then 252 harvested 24 hours later. The NEK9-targeted siRNA was that reported by Pelka et al (32) with 253 the sequence GACCAUCCGUUCCAAUAGCtt. The GMIP-targeted siRNA was designed using 254 BLOCK-iT™ RNAi designer (Invitrogen), and the sequences was 255
GGAAGAGGUACAGUGACAUtt. siRNAs were synthesized by Invitrogen. 256
RESULTS
260
Identification of herpesvirus proteins that induce G1/S accumulation. To gain a more 261 comprehensive understanding of which herpesvirus proteins contribute to G1/S arrest of the cell 262 cycle, we screened a plasmid library consisting of 234 FLAG-tagged ORFs from HSV-1, EBV 263 and CMV for effects on Fucci cells (26). For a list of all of the protein in our screen, see Table  264 S1 in Salsman et al (23). fold or more are shown in Table 1 . The 1.8-fold cut off was chosen to limit further analyses to 285 ~20% of the screened proteins with the strongest effects. EBV had the highest proportion of 286 proteins that induced G1/S accumulation, while CMV had the lowest. Many of the functionally 287 characterized proteins that we identified as increasing G1/S 1.8-fold or more could be 288 categorized as early, tegument or capsid/capsid assembly proteins, while several were 289 completely uncharacterized (Table 1) . While it is not unexpected that early and tegument 290 proteins have roles in altering the cell cycle, we were surprised to find that capsid proteins 291 consistently did so. This suggests that, like the incoming tegument proteins, capsids that are 292 delivered to the cell may have roles in altering cell cycle progression. Results with individual 293 EBV, HSV-1 and CMV proteins that increase G1/S are shown in Tables 2, 3 DNA content as G1 cells, we expected proteins that increased G1/S accumulation to display 311 increased G1 DNA content and decreased S phase DNA content using this assay. This was 312 confirmed to various degrees for all of the EBV proteins examined, but was not seen when the 313 FLAG epitope was expressed on its own as a negative control (Fig. 2C) . We also quantified 314 effects of the proteins on S-phase by measuring incorporation of bromodeoxyuridine (BrdU) in 315 FLAG-positive and FLAG-negative transfected CNE2Z cells (sorted by FACS), after pulse 316 labeling with this nucleotide analogue. Consistent with the DNA content analysis, all of the 317 proteins decreased BrdU incorporation, indicating that fewer cells were in S phase ( Fig. 2A, B  318 and C). These results are consistent with a role for these proteins in causing G1/S accumulation, 319 indicating that this cell cycle effect is not particular to Fucci cells. 320
Five of the seven EBV proteins analyzed above have homologues in HSV-1 and CMV. 321
To determine if the cell cycle effect of the EBV proteins is conserved in other herpesviruses, we 322 compared the effects of the available homologues in the FACS-based colourimetric assay in 323
Fucci cells. For each of the five EBV proteins, at least 1 homologue in HSV-1 or CMV also 324 caused an increase in G1/S cells, suggesting a conservation of the cell cycle function (Table 5) . 325 protein kinase) and GMIP (GEM-interacting protein). Interestingly, NEK9 has multiple effects on 373 the cell cycle, including modulating G1/S progression (42). GMIP is a member of the ARHGAP 374 family of Rho/Rac/Cdc42-like GTPase activating proteins, which specifically stimulate the 375
GTPase activity of RhoA (43). Although a direct role for GMIP during G1/S progression has not 376 been established, RhoA has been shown to influence G1/S transition by several mechanisms 377 including p21 regulation (44) and modulation of INK4 family members (45). 378
Interactions of BGLF2 with NEK9 and GMIP were confirmed by FLAG 379 immunoprecipitation of BGLF2 from CNE2Z extracts, followed by Western blotting with 380 antibodies specific to NEK9 and GMIP (Fig. 5B) . In contrast, NEK9 and GMIP were not 381 recovered in FLAG immunoprecipitations performed with CNE2Z extracts containing pMZS3F 382 or pMZS3F-LacZ. We also examined the effect of BGLF2 on the localization of NEK9 and 383 GMIP by immunofluorescence microscopy. In untransfected cells (data not shown) or CNE2Z 384 cells transfected with pMZS3F (Fig. 5C ), NEK9 appeared largely cytoplasmic in virtually all 385 (~95%) of the cells. However, in the presence of BGLF2, NEK9 was largely pancellular, 386 reflecting the localization of BGLF2 (Fig. 5C ). The pancellular localization of NEK9 was seen 387 in 93% of BGLF2-expressing cells. In untransfected or pMZS3F-transfected cells, GMIP was 388 predominantly cytoplasmic, with a lesser amount of staining in the nucleus (Fig. 5C ). In cells 389 expressing BGLF2, the nuclear staining of GMIP was increased to various degrees, resulting in 390 more pancellular staining similar to that of BGLF2. The results confirm the mass spectrometry 391 data that BGLF2 interacts with NEK9 and GMIP. 
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Herpesviruses can impact cellular processes immediately upon infection by packaging 418 specific viral proteins in the tegument of the virion, such that they are delivered to the cell upon 419 initial infection. Therefore, it is not unexpected that some of the G1/S-inducing proteins would 420 be tegument proteins. Indeed, our screen identified five tegument proteins (3 from EBV, 2 from 421 CMV, 1 from HSV-1) that increased the population of cells at G1/S, and two of these (EBV 422 BGLF2 and BKRF4) have not been previously studied. Of the three EBV tegument proteins that 423 we identified as inducing G1/S, only the BGLF4 Ser/Thr protein kinase has been functionally 424 characterized. Among the various functions reported for BGLF4 is the ability to inhibit cell cycle 425 progression, particularly at the G1/S interface (37). Our results are in agreement with this 426 conclusion. One of the two CMV tegument proteins that we identified as increasing G1/S cells 427 was UL69, which was previously reported to shift cells to the G1 compartment according to 428
for their effect on all of these proteins. While we did not see consistent induction or activation 464 (phosphorylation) of pRB, ATM or Chk2, BMRF1 and BORF2 were found to consistently 465 induce the level of total and Ser15-phosphorylated p53. Interestingly, despite inducing p53, both 466 proteins failed to induce the p53 target gene p21, suggesting that they disable downstream 467 functions of p53. While both BMRF1 and BORF2 have roles in DNA replication, as the DNA 468 polymerase processivity factor and the ribonucleotide reductase large subunit (RR1), 469 respectively, there is reason to believe that these proteins may have additional functions in 470 silenced. The results as a whole suggest that BGLF2 induces p21 by interfering with the 510 functions of NEK9 and GMIP. Interestingly, this is not the first report of a viral protein targeting 511 NEK9, as adenovirus E1A was previously shown to interact with NEK9 and alter its subcellular 512 localization (32). 513
In conclusion, we have used the Fucci cell system to identify several herpesvirus proteins 514 that induce cells to accumulate at the G1/S interface. This provided the first functional 515 information for 5 EBV, 3 HSV-1 and 6 CMV proteins, including BGLF2, which we have shown 516 to induce p21 protein levels in a manner that is p53-independent but involves NEK9 and GMIP. 517
In addition, our results provide the first indication that herpesvirus capsid proteins can affect 518 cellular processes, including cell cycle progression. Our study as a whole suggests that multiple 519 viral proteins and mechanisms contribute to G1/S arrest typical of herpesvirus lytic infections. 520
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